DC Field | Value | Language |
---|---|---|
dc.contributor.author | van de Ven, Anne L. | ko |
dc.contributor.author | Kim, Pilhan | ko |
dc.contributor.author | Haley, O'Hara | ko |
dc.contributor.author | Fakhoury, Jean R. | ko |
dc.contributor.author | Adriani, Giulia | ko |
dc.contributor.author | Schmulen, Jeffrey | ko |
dc.contributor.author | Moloney, Padraig | ko |
dc.contributor.author | Hussain, Fazle | ko |
dc.contributor.author | Ferrari, Mauro | ko |
dc.contributor.author | Liu, Xuewu | ko |
dc.contributor.author | Decuzzi, Paolo | ko |
dc.contributor.author | Yun, Seok Hyun | ko |
dc.date.accessioned | 2013-03-09T10:50:31Z | - |
dc.date.available | 2013-03-09T10:50:31Z | - |
dc.date.created | 2012-04-02 | - |
dc.date.created | 2012-04-02 | - |
dc.date.issued | 2012-02 | - |
dc.identifier.citation | JOURNAL OF CONTROLLED RELEASE, v.158, no.1, pp.148 - 155 | - |
dc.identifier.issn | 0168-3659 | - |
dc.identifier.uri | http://hdl.handle.net/10203/96139 | - |
dc.description.abstract | Nanoparticles for cancer therapy and imaging are designed to accumulate in the diseased tissue by exploiting the Enhanced Permeability and Retention (EPR) effect. This limits their size to about 100 nm. Here, using intravital microscopy and elemental analysis, we compare the in vivo localization of particles with different geometries and demonstrate that plateloid particles preferentially accumulate within the tumor vasculature at unprecedented levels, independent of the EPR effect. In melanoma-bearing mice, 1000 x 400 nm plateloid particles adhered to the tumor vasculature at about 5% and 10% of the injected dose per gram organ (ID/g) for untargeted and RGD-targeted particles respectively, and exhibited the highest tumor-to-liver accumulation ratios (0.22 and 0.35). Smaller and larger plateloid particles, as well as cylindroid particles, were more extensively sequestered by the liver, spleen, and lungs. Plateloid particles appeared well-suited for taking advantage of hydrodynamic forces and interfacial interactions required for efficient tumoritropic accumulation, even without using specific targeting ligands. (c) 2011 Elsevier B.V. All rights reserved. | - |
dc.language | English | - |
dc.publisher | ELSEVIER SCIENCE BV | - |
dc.subject | POROUS SILICON MICROPARTICLES | - |
dc.subject | HUMAN TUMOR XENOGRAFT | - |
dc.subject | IN-VIVO | - |
dc.subject | MACROMOLECULAR THERAPEUTICS | - |
dc.subject | VASCULAR-PERMEABILITY | - |
dc.subject | DELIVERY-SYSTEM | - |
dc.subject | CANCER-THERAPY | - |
dc.subject | DRUG-DELIVERY | - |
dc.subject | SOLID TUMORS | - |
dc.subject | BLOOD-FLOW | - |
dc.title | Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution | - |
dc.type | Article | - |
dc.identifier.wosid | 000302605900018 | - |
dc.identifier.scopusid | 2-s2.0-84857914530 | - |
dc.type.rims | ART | - |
dc.citation.volume | 158 | - |
dc.citation.issue | 1 | - |
dc.citation.beginningpage | 148 | - |
dc.citation.endingpage | 155 | - |
dc.citation.publicationname | JOURNAL OF CONTROLLED RELEASE | - |
dc.identifier.doi | 10.1016/j.jconrel.2011.10.021 | - |
dc.contributor.localauthor | Kim, Pilhan | - |
dc.contributor.nonIdAuthor | van de Ven, Anne L. | - |
dc.contributor.nonIdAuthor | Haley, O'Hara | - |
dc.contributor.nonIdAuthor | Fakhoury, Jean R. | - |
dc.contributor.nonIdAuthor | Adriani, Giulia | - |
dc.contributor.nonIdAuthor | Schmulen, Jeffrey | - |
dc.contributor.nonIdAuthor | Moloney, Padraig | - |
dc.contributor.nonIdAuthor | Hussain, Fazle | - |
dc.contributor.nonIdAuthor | Ferrari, Mauro | - |
dc.contributor.nonIdAuthor | Liu, Xuewu | - |
dc.contributor.nonIdAuthor | Decuzzi, Paolo | - |
dc.type.journalArticle | Article | - |
dc.subject.keywordAuthor | Nanoparticles | - |
dc.subject.keywordAuthor | Size and shape | - |
dc.subject.keywordAuthor | Biodistribution | - |
dc.subject.keywordAuthor | Tumor accumulation | - |
dc.subject.keywordAuthor | Rational design | - |
dc.subject.keywordAuthor | Intravital microscopy | - |
dc.subject.keywordPlus | POROUS SILICON MICROPARTICLES | - |
dc.subject.keywordPlus | HUMAN TUMOR XENOGRAFT | - |
dc.subject.keywordPlus | IN-VIVO | - |
dc.subject.keywordPlus | MACROMOLECULAR THERAPEUTICS | - |
dc.subject.keywordPlus | VASCULAR-PERMEABILITY | - |
dc.subject.keywordPlus | DELIVERY-SYSTEM | - |
dc.subject.keywordPlus | CANCER-THERAPY | - |
dc.subject.keywordPlus | DRUG-DELIVERY | - |
dc.subject.keywordPlus | SOLID TUMORS | - |
dc.subject.keywordPlus | BLOOD-FLOW | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.